Skip to main content
CDC Website

Counseling

What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Rifampin

Submitted by Pratima Nimboorkar in on

This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine

Submitted by Edith Jickling in on

This Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Teen Dating Violence

Submitted by Edith Jickling in on

General information on teen dating violence.

NVHR-Sponsored Webinar on Hepatitis C in California: The Role of the Primary Care Team

Submitted by Anonymous (not verified) in on

This webinar described the role of primary care providers in hepatitis C. It provided an epidemiological overview of hepatitis C nationally and in California; reviewed hepatitis C testing recommendations and the role of PCPS in screening, diagnosis, and care; and spotlighted a case study on initiating hepatitis C Baby Boomer hepatitis C screening in primary care.

Hepatitis C Treatment Access: State Level Advocacy Successes

Submitted by Anonymous (not verified) in on

This webinar highlighted the work of four advocates who have led successful efforts to expand access to hepatitis C treatment in their states. They shared their strategies, lessons learned, and advice for advocates in other states. The webinar included four panelist presentations followed by time for Q&A and discussion.